American Society of Nephrology honors leaders in the fight against kidney diseases

Washington, DC (November 9, 2019) — The American Society of Nephrology (ASN) will honor leaders in the fight against kidney disease during ASN Kidney Week 2019, the society’s annual meeting, held November 5-10 at the Walter E. Washington Convention Center in Washington, DC. The awards recognize five individuals with significant accomplishments in research, education, and…

Details

Examining muscle relaxant dose, risk of encephalopathy in patients with CKD

What The Study Did: Whether a higher or lower dose of the muscle relaxant baclofen was associated with 30-day risk of hospitalization with encephalopathy (defined as a main diagnosis of delirium, disorientation, transient alteration of awareness, transient ischemic attack or an unclear diagnosis of dementia) among newly prescribed patients with chronic kidney disease was the…

Details